Menu Search
Equities

Lepu Biopharma Co Ltd

2157:HKG.HS

Lepu Biopharma Co Ltd

Actions
  • Price (HKD)3.10
  • Today's Change0.17 / 5.80%
  • Shares traded3.75m
  • 1 Year change-38.86%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in CNYView more

In 2023, cash reserves at Lepu Biopharma Co Ltd fell by 243.38m. However, Cash Flow from Investing totalled 18.26m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 250.84m for operations while cash used for financing totalled 11.01m.
Cash flow per share0.0071
Price/Cash flow per share421.51
Book value per share0.5885
Tangible book value per share0.31
More ▼

Balance sheet in CNYView more

Lepu Biopharma Co Ltd has a Debt to Total Capital ratio of 46.21%, a higher figure than the previous year's 36.96%.
Current ratio0.7548
Quick ratio0.7322
Total debt/total equity0.8471
Total debt/total capital0.4621
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.